Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma.
about
IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer.Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma.The pathological significance of Notch1 in oral squamous cell carcinoma.Increased expression of Lin28B associates with poor prognosis in patients with oral squamous cell carcinomaLymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective studyImmunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer.Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.The non-canonical role of vascular endothelial growth factor-C axis in cancer progressionEGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC.Rapamycin targets Interleukin 6 (IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells.Interleukin-6 as a therapy target in oral squamous carcinoma.Lymphatic vessels: new targets for the treatment of inflammatory diseases.Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma.IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma.Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo.Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells.Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.Regulatory Role of the MicroRNA-29b-IL-6 Signaling in the Formation of Vascular Mimicry.Tumor-related interleukins: old validated targets for new anti-cancer drug development.Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis.The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis.The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy.Prognostic impact of preoperative serum interleukin-6 levels in patients with early-stage oral squamous cell carcinoma, defined by sentinel node biopsy.Clinical Roles of Interleukin-6 and STAT3 in Oral Squamous Cell Carcinoma.
P2860
Q30981861-8527C81A-32F1-4226-A47A-FF98B4D1A936Q34491048-42E527CD-90FF-4572-9BA6-7149AC9FA2C8Q34655317-A65AFEF7-BD9C-4251-B4B0-0C03575DED5EQ35080717-5CFCEC1D-3A00-4CEC-86F7-FFF5C1F8DA32Q35174365-0DC27929-0BAD-4C26-B5C2-F245C636C406Q35342995-C93DA053-79ED-41B9-8BA5-CBBE08232429Q35739397-14EDB8DC-9705-48F3-B76F-740066524956Q35905137-385E07A7-DB0B-47D1-AF5C-2BE872921D8CQ35955383-4801E9D9-424E-4C83-BDA9-06F45422A74EQ36068960-365D0664-460B-4523-A998-50F5CC820065Q36589860-4CC5CF57-9CE2-461E-90B2-067ED35CF027Q37071029-66630EAF-9BFC-453D-B013-A94355AA3FDBQ37407594-CAAAFCAC-CCC3-4792-A634-485A876FDB3EQ37448156-CB366291-DF87-4A16-A6E1-998B07C2272FQ38055760-949568C0-ACD0-442B-B6C6-C1678DF9D06DQ38161374-8D680BE2-A9D1-4578-880E-70C2E03431FEQ38696829-57740117-E24E-4F11-9C3E-0B7BDB3B554FQ38741339-9B5EDE7F-70CB-48DB-8660-64D57F6D13CDQ39081980-FCCB2B77-EFE4-4501-A218-D31841FB6B8CQ39094265-6A1DE7A5-02E5-4F90-9987-C9434B51C2BCQ39676371-7031C204-1E40-46A9-8BCE-C40F8A60FC59Q40984509-F665C804-BF8E-4E19-AC5A-E168A925F6D3Q41716360-FEDD5812-6E52-4844-9241-FEF1C65EDEBDQ42281477-5ABA91BC-3E8B-4BFE-B142-8147BCAE0186Q42366665-36F4A695-86B7-4552-97E3-1D29DD112FACQ47273007-939F36ED-6B7B-41D6-811E-E96A090F1F9FQ49382508-2122822D-E5A2-4205-80C8-E1BE03EF7685Q51389976-DF2AAECA-C53C-45D0-A0A1-08602BDB8044
P2860
Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Interleukin-6 signalling regul ...... oral squamous cell carcinoma.
@en
Interleukin-6 signalling regul ...... oral squamous cell carcinoma.
@nl
type
label
Interleukin-6 signalling regul ...... oral squamous cell carcinoma.
@en
Interleukin-6 signalling regul ...... oral squamous cell carcinoma.
@nl
prefLabel
Interleukin-6 signalling regul ...... oral squamous cell carcinoma.
@en
Interleukin-6 signalling regul ...... oral squamous cell carcinoma.
@nl
P2093
P2860
P356
P1476
Interleukin-6 signalling regul ...... oral squamous cell carcinoma.
@en
P2093
Akimitsu Hiraki
Hideki Nakayama
Hirofumi Jono
Kazutoshi Ota
Masanori Shinohara
Mitsuharu Ueda
Mutsuko Ibusuki
Satoru Shinriki
Takanao Sueyoshi
Tomoko Ota
P2860
P304
P356
10.1002/PATH.2935
P577
2011-06-25T00:00:00Z